Navigation Links
ADVENTRX Reports Second Quarter 2011 Financial Results
Date:8/8/2011

2010. Included in the net loss applicable to common stock for the second quarter of 2010 was a non-cash, deemed dividend expense of $3.1 million incurred in connection with the Company's May 2010 equity financing.

Research and development (R&D) expenses for the second quarter of 2011 were $1.3 million, an increase of $0.7 million, or 112%, compared to $0.6 million for the same period in 2010. The increase was due primarily to a $0.5 million increase in external nonclinical study fees and expenses and a $0.2 million increase in external bioequivalence and clinical trial fees and expenses.  The increase in external nonclinical study fees and expenses resulted primarily from a $0.5 million increase in research-related manufacturing expenses for Exelbine™.  The increase in external bioequivalence and clinical trial fees and expenses is primarily related to increased clinical trial work of $0.1 million for Exelbine™ and clinical consulting expenses of $0.1 million for ANX-188.

Selling, general and administrative (SG&A) expenses for the second quarter of 2011 were $1.8 million, an increase of $0.5 million, or 40%, compared to $1.3 million for the same period in 2010. The increase was due primarily to a $0.2 million increase in personnel costs, mainly due to an accrual for estimated bonus expense related to 2011 performance, and a $0.3 million increase in commercial-readiness activities for Exelbine™.

Transaction-related expenses for the second quarter of 2011 were $1.2 million compared to $0 for the same period in 2010.  Transaction-related expenses consisted of $1.0 million related to legal, accounting, financial and business development advisory fees associated with the evaluation of potential acquisition targets, including SynthRx, and $0.2 million related to changes in the fair value of contingent consideration related to the SynthRx acquisition.

Year-to-Date Operating ResultsADVENTRX's net loss
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at the 31st Annual Canaccord Genuity Growth Conference on August 11
2. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
3. ADVENTRX Reports First Quarter 2011 Financial Results
4. ADVENTRX Completes Acquisition of SynthRx
5. ADVENTRX Pharmaceuticals Provides Update on ANX-514
6. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
7. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
8. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
9. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
10. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
11. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  The U.S. Food and ... -- the first biosimilar product approved in ... toward growth in the contract manufacturing organization (CMO) ... industry is geared to the production of small-molecular ... biopharmaceutical products. The healthcare market research publisher,s report, ...
(Date:5/22/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) ... to Prepare Application Dossiers for Oversea Medical device ... report to their offering. The ... market of the most growth potentiality, which is ... and producers to penetrate such market. It is ...
(Date:5/22/2015)... -- Richmond Pharmacology is a university ... worldwide reputation for excellence in clinical trials. It ... reviewed medical journals. Its officers are engaged with ... about rules for transparency and publication of clinical ... Clinical research is conducted worldwide, therefore ...
Breaking Medicine Technology:Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
(Date:5/26/2015)... Many sexy cocktail dresses inspired by celebrities have ... Now, TheCelebrityDresses.com is offering great discounts on all ... The company aims to help ladies from all ... on valuable, trendy formal outfits. , TheCelebrityDresses.com is ... occasion dresses. Their dresses are popular among both ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 U.S. Food ... in the United States are extensive and can be ... firm that helps medical device companies comply with FDA ... medical device companies navigate FDA requirements. , 1. ... the United States can be a lengthy process depending ...
(Date:5/26/2015)... Carl W. Berk, M.D. and his ... Pinehurst, N.C. have launched a Balloon Sinuplasty website to ... sinusitis and the benefits of Balloon Sinuplasty. , The ... determine if someone is a good candidate for Balloon ... factors that can contribute to chronic nasal congestion. If ...
(Date:5/25/2015)... 26, 2015 The National Association ... a 2015-2016 inductee into its VIP Professional Woman of ... distinction for leadership in dentistry. NAPW is the nation's ... than 700,000 members and over 200 operating local chapters. ... exceptional group of professional women,” said NAPW President Star ...
(Date:5/25/2015)... 2015 World Patent Marketing, a vertically ... Hidee-Hose, an undergarment patent that allays women’s fears when ... Hosiery industry forecasts the market to reach $20.3 billion ... Director of World Patent Marketing , "The largest ... and is expected to maintain its lead. The industry ...
Breaking Medicine News(10 mins):Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3
... Boston have uncovered important molecular and genetic keys to ... researchers and clinicians additional targets to stop the growth ... Proceedings of the National Academy of Sciences , ... Ras and mTOR pathways) that are common in tumor ...
... report appearing in the December issue of the FASEB ... United Kingdom have developed a simple blood test to detect ... possible because scientists found a substance in the blood, called ... and then developed a way to identify its presence in ...
... which mobilizes hematopoietic and other types of stem cells to ... CXCL12 also guides these cells to sites at which the ... blood flow. These capabilities have made CXCL12 and its cognate ... effects of damage to the heart caused by myocardial infarction. ...
... NY Scientists investigating the interactions, or binding patterns, ... the entire genome in normal human cells have turned ... The distinct binding patterns reflect differences in the chromatin ... be important for understanding the function of the tumor ...
... Some of the nastiest smelling creatures on Earth have ... substances that hold promise for becoming new weapons in ... research on amphibians so smelly (like rotten fish, for ... ACS, Journal of Proteome Research . Yun ...
... the earliest known impairments caused by Alzheimer,s disease - loss of ... protein in a mouse model of the disease, a study led ... The study confirms that the protein, called amyloid beta, causes ... sense of smell to determine if someone may get Alzheimer,s disease, ...
Cached Medicine News:Health News:Unlocking the genetic and molecular mystery of soft-tissue sarcoma 2Health News:Simple blood test diagnoses Parkinson's disease long before symptoms appear 2Health News:Promising and perilous? The ambivalent role of the CXCL12/ CXCR4 axis in heart repair 2Health News:First analysis of tumor-suppressor interactions with whole genome in normal human cells 2Health News:First analysis of tumor-suppressor interactions with whole genome in normal human cells 3Health News:First analysis of tumor-suppressor interactions with whole genome in normal human cells 4Health News:Early sign of Alzheimer's reversed in lab 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Medicine Products: